Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Internal Medicine"
DOI: 10.1001/jamainternmed.2024.4346
Abstract: Key Points Question Does treatment with semaglutide, 2.4 mg, once weekly affect the risk of developing symptoms of depression or suicidal ideation/behavior vs placebo in people with overweight or obesity without known major psychopathology? Findings… read more here.
Keywords: semaglutide; suicidal ideation; major psychopathology; known major ... See more keywords